Literature DB >> 8882081

Reduced beta adrenoceptor density in vivo in human lung tumours: a preliminary study with positron emission tomography.

F Qing1, M J Hayes, C G Rhodes, T Krausz, S W Fountain, M M Burke, T Jones, J M Hughes.   

Abstract

BACKGROUND: Reduced beta adrenergic receptor density in tumours has been reported in previous in vitro studies. The aim of the present study was to assess whether this occurs in vivo.
METHODS: Pulmonary beta adrenoceptors were imaged and quantified in vivo using positron emission tomography (PET) and the beta antagonist radioligand (S)-[11C]CGP-12177 in five men with lung tumours of mean age 58 years (range 42-68). The histology of the tumours was squamous cell carcinoma in two cases, adenocarcinoma in one, carcinoid tumour in one, and large cell carcinoma in one. The regional blood volume and extravascular tissue density were also measured using PET. Regions of interest were drawn for both non-tumour and tumour lung tissue.
RESULTS: The mean (SD) blood volume was 0.142 (0.025) ml/ml in tumour regions and 0.108 (0.010) ml/ml in normal lung regions--a difference of 31%. Mean (SD) extravascular tissue density was 0.653 (0.133) g/ml in tumour regions, substantially higher than in normal lung regions (0.157 (0.021) g/ml). On the contrary, beta receptor density was 5.1 (1.8) pmol/g in tumour regions, lower than the value of 9.9 (1.6) pmol/g found in adjacent normal lung--a difference of 48%.
CONCLUSIONS: In vivo beta adrenoceptor density is reduced in human lung tumours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882081      PMCID: PMC472497          DOI: 10.1136/thx.51.7.727

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

Review 1.  Early signals in the mitogenic response.

Authors:  E Rozengurt
Journal:  Science       Date:  1986-10-10       Impact factor: 47.728

2.  The role of cAMP in regulating tumour cell growth.

Authors:  M M Gottesman; R D Fleischmann
Journal:  Cancer Surv       Date:  1986

3.  Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells.

Authors:  R J Hughes; M J Howard; J M Allen; P A Insel
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

Review 4.  Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation.

Authors:  Y S Cho-Chung; T Clair; P Tagliaferri; S Ally; D Katsaros; G Tortora; L Neckers; T L Avery; G W Crabtree; R K Robins
Journal:  Cancer Invest       Date:  1989       Impact factor: 2.176

5.  Breast cancer: PET imaging of estrogen receptors.

Authors:  M A Mintun; M J Welch; B A Siegel; C J Mathias; J W Brodack; A H McGuire; J A Katzenellenbogen
Journal:  Radiology       Date:  1988-10       Impact factor: 11.105

6.  Response of C-6 glioma to isoproterenol and papaverine in vivo depends on beta-adrenergic receptor density.

Authors:  E Chelmicka-Schorr; M G Sportiello; S F Atweh; B G Arnason
Journal:  Ann Neurol       Date:  1984-01       Impact factor: 10.422

7.  C-6 glioma growth in rats: suppression with a beta-adrenergic agonist and a phosphodiesterase inhibitor.

Authors:  E Chelmicka-Schorr; B G Arnason; S J Holshouser
Journal:  Ann Neurol       Date:  1980-10       Impact factor: 10.422

8.  Sympathetic nervous system and glioma growth.

Authors:  R L Kinnard; E Chelmicka-Schorr; M E Checinski; K H Jones; B G Arnason
Journal:  Eur J Cancer Clin Oncol       Date:  1986-04

9.  Platelet-derived growth factor elicits cyclic AMP accumulation in Swiss 3T3 cells: role of prostaglandin production.

Authors:  E Rozengurt; P Stroobant; M D Waterfield; T F Deuel; M Keehan
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

10.  Positron emission tomography. A new tool for characterization of malignant disease and selection of therapy.

Authors:  W J Koh; T W Griffin; J S Rasey; G E Laramore
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.